A blueprint for a much-needed new generation of tuberculosis (TB) treatment has been developed by a team of scientists led at the University of Strathclyde in Glasgow. TB was once thought to have been eradicated but has become a major killer again in recent years, claiming two million lives annually - or one every fifteen seconds - and infecting about a third of the world's population.